Tromboembolismo pulmonar

Pulmonary embolism (PE) has highly variable clinical presentation, ranging from completely asymptomatic patients, in which the diagnosis is made incidentally, to situations where massive emboli lead the patient quickly to death. Its diagnosis is difficult and depends on analysis of pre-test probability for optimum accuracy of diagnostic procedures. The hallmark of treatment is anticoagulation, but the chemical thrombolysis should be considered in cases of hemodynamic instability.O tromboembolismo pulmonar (TEP) tem quadro clínico bastante variável, que vai desde quadros completamente assintomáticos, nos quais o diagnóstico é feito incidentalmente, até situações em que êmbolos maciços levam o paciente rapidamente à morte. Seu diagnóstico é difícil e depende da análise da probabilidade pré-teste para otimização da acurácia dos métodos diagnósticos complementares. A pedra angular do tratamento é anticoagulação, porém a trombólise química deve ser considerada em casos de instabilidade hemodinâmica

Uso racional de antimicrobianos

The inadequate administration of antimicrobials may compromise the clinical response of the patient, increase the costs during hospitalization and contribute to the appearance of multiresistant bacteria. In this context, the use of rational antimicrobials is beneficial to the infected patient and also to the health institution. The prescription of this drug type must take in account the host, the infectious agent and the antimicrobial itself. Thus, its utilization must be based on the knowledge of the concepts of colonization, contamination and infection, notions of clinical microbiology, culture collection, and habitual microbiota of the human body, and mechanisms, action specter, pharmacokinetics, pharmacodynamics and side effects of the antimicrobials. The revision of these topics pursuits to provide subsidies to the choice of the most adequate antimicrobial to the type of infection, foreseen treatment time, failure criteria and clinical answer to the prescribed drug, besides guide possible change of therapy along the treatment.A administração inadequada de antimicrobianos é capaz de comprometer a resposta clínica do paciente, aumentar custos com internação e contribuir para o surgimento de bactérias multirresistentes. Nesse contexto, o uso racional de antimicrobianos é benéfico para o paciente infectado e também para a instituição de saúde. A indicação desta classe de drogas deve levar em conta o hospedeiro, o agente infeccioso e o antimicrobiano propriamente dito. Assim, sua utilização deve ser baseada no conhecimento dos conceitos de colonização, contaminação e infecção, noções de microbiologia clínica, coleta de culturas, microbiota habitual do corpo humano, e mecanismos, espectro de ação, farmacocinética, farmacodinâmica e efeitos colaterais dos antimicrobianos. A revisão desses tópicos procura fornecer subsídios para escolha do antimicrobiano mais adequado para o tipo de infecção, tempo de tratamento previsto, critérios de falha e resposta clínica à droga prescrita, além de nortear possível troca de terapia ao longo do tratamento

Dengue: transmissão, aspectos clínicos, diagnóstico e tratamento

A dengue é uma arbovirose transmitida principalmente pela picada do mosquito Aedes aegypti. Pode ser assintomática ou apresentar amplo espectro clínico, variando de doença febril autolimitada até formas graves, que podem evoluir com choque circulatório e óbito. Para evitar esse desfecho, a precocidade no diagnóstico da doença e na detecção de sinais de alarme, que indicam evolução desfavorável; assim como a instituição de tratamento adequado, são fundamentais. Não há tratamento específico, ele é apenas sintomático e de suporte. Até o momento, não existe vacina disponível para prevenção da doença, sendo o controle do vetor a medida mais efetiva.  Dengue is an arbovirus transmitted mainly by the bite of the mosquito Aedes aegypti.It can be asymptomatic or present a wide clinical spectrum, ranging from self-limited febrile illness to severe forms that could evolve with circulatory shock and death. In order to avoid this outcome, early diagnosis of disease and the detection of warning signs that indicate unfavorable, as well as adequate treatment are essential, There is no specific treatment, it is only symptomatic and supportive. Up to now, there is no vaccine available for prevention of disease, vector control the most effective measure.  

Multivariate Analysis Applied to Forestry Agricultural Sciences: The Model-Directed Study

This is a literature review that aimed to find articles that exemplify and describe the use of multivariate analysis in different fields of Forest Agricultural Sciences, considering effective practices using multivariate statistical techniques for the simultaneous processing of data. For data collection were selected for the meta-analysis of 70 technical articles of which 54 were employed in the study directed to the use of multivariate techniques applied in the areas of agricultural sciences. The results showed thatstudies directed to certain areas within the Forest Agricultural Sciences exhibit some regularity in the use of multivariate analysis, and most application analyzes were more usual as the Cluster Analysis (AA) and Principal Component Analysis (PCA). Thus the use of multivariate analysis studies and evaluations of experiments in Agricultural Sciences proved to great value to allow greater clarity and better interpretation of dealing with complex phenomena

Chloroplast genome assembly of Serjania erecta Raldk: comparative analysis reveals gene number variation and selection in protein-coding plastid genes of Sapindaceae

Serjania erecta Raldk is an essential genetic resource due to its anti-inflammatory, gastric protection, and anti-Alzheimer properties. However, the genetic and evolutionary aspects of the species remain poorly known. Here, we sequenced and assembled the complete chloroplast genome of S. erecta and used it in a comparative analysis within the Sapindaceae family. S. erecta has a chloroplast genome (cpDNA) of 159,297 bp, divided into a Large Single Copy region (LSC) of 84,556 bp and a Small Single Copy region (SSC) of 18,057 bp that are surrounded by two Inverted Repeat regions (IRa and IRb) of 28,342 bp. Among the 12 species used in the comparative analysis, S. erecta has the fewest long and microsatellite repeats. The genome structure of Sapindaceae species is relatively conserved; the number of genes varies from 128 to 132 genes, and this variation is associated with three main factors: (1) Expansion and retraction events in the size of the IRs, resulting in variations in the number of rpl22, rps19, and rps3 genes; (2) Pseudogenization of the rps2 gene; and (3) Loss or duplication of genes encoding tRNAs, associated with the duplication of trnH-GUG in X. sorbifolium and the absence of trnT-CGU in the Dodonaeoideae subfamily. We identified 10 and 11 mutational hotspots for Sapindaceae and Sapindoideae, respectively, and identified six highly diverse regions (tRNA-Lys — rps16, ndhC – tRNA-Val, petA – psbJ, ndhF, rpl32 – ccsA, and ycf1) are found in both groups, which show potential for the development of DNA barcode markers for molecular taxonomic identification of Serjania. We identified that the psaI gene evolves under neutrality in Sapindaceae, while all other chloroplast genes are under strong negative selection. However, local positive selection exists in the ndhF, rpoC2, ycf1, and ycf2 genes. The genes ndhF and ycf1 also present high nucleotide diversity and local positive selection, demonstrating significant potential as markers. Our findings include providing the first chloroplast genome of a member of the Paullinieae tribe. Furthermore, we identified patterns in variations in the number of genes and selection in genes possibly associated with the family’s evolutionary history

Diminishing benefits of urban living for children and adolescents’ growth and development

Optimal growth and development in childhood and adolescence is crucial for lifelong health and well-being1–6. Here we used data from 2,325 population-based studies, with measurements of height and weight from 71 million participants, to report the height and body-mass index (BMI) of children and adolescents aged 5–19 years on the basis of rural and urban place of residence in 200 countries and territories from 1990 to 2020. In 1990, children and adolescents residing in cities were taller than their rural counterparts in all but a few high-income countries. By 2020, the urban height advantage became smaller in most countries, and in many high-income western countries it reversed into a small urban-based disadvantage. The exception was for boys in most countries in sub-Saharan Africa and in some countries in Oceania, south Asia and the region of central Asia, Middle East and north Africa. In these countries, successive cohorts of boys from rural places either did not gain height or possibly became shorter, and hence fell further behind their urban peers. The difference between the age-standardized mean BMI of children in urban and rural areas was <1.1 kg m–2 in the vast majority of countries. Within this small range, BMI increased slightly more in cities than in rural areas, except in south Asia, sub-Saharan Africa and some countries in central and eastern Europe. Our results show that in much of the world, the growth and developmental advantages of living in cities have diminished in the twenty-first century, whereas in much of sub-Saharan Africa they have amplified

Cardiovascular risk rate in hypertensive patients attended in primary health care units: the influence of pharmaceutical care

Cardiovascular complications are relevant due to their frequency and severity on the hypertension scenario. Studies refer Pharmaceutical Care (PC) as capable of decreasing cardiovascular risk rate (%CVR) on hypertensive patients. This study aimed to investigate, through a randomized clinical assay, the influence of PC service on the %CVR of hypertensive patients assisted in a health primary care unit from Fortaleza-Ceará. Two study groups were formed: i. Intervention Group (IG), which received orientation about taking medicines, actions aiming to prevent/solve medicine interactions and adverse effects and non-pharmacological interventions for 9 months and, ii. Control Group (CG), which received traditional assistance of the unit and was monitored during the same period. It was observed a statistically significant reduction on %CVR (10.76 to 7.86; p=0.04) and systolic blood pressure levels (SBP) (137.69 to 131.54; p<0.01) in the IG, while, in the CG, there was no significant alteration. 151 Drug Related Problem (DRP) were identified and it was realized 124 pharmaceutical interventions, with 89.2% of them resulting on solution/prevention of the problem. Our findings indicated that the inclusion of the PC service in the hypertensive health assistance was more effective at the %CVR and the SBP reduction in comparison to the traditional assistance offered

Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants

© The Author(s) 2018. Background: Change in the prevalence of raised blood pressure could be due to both shifts in the entire distribution of blood pressure (representing the combined effects of public health interventions and secular trends) and changes in its high-blood-pressure tail (representing successful clinical interventions to control blood pressure in the hypertensive population). Our aim was to quantify the contributions of these two phenomena to the worldwide trends in the prevalence of raised blood pressure. Methods: We pooled 1018 population-based studies with blood pressure measurements on 88.6 million participants from 1985 to 2016. We first calculated mean systolic blood pressure (SBP), mean diastolic blood pressure (DBP) and prevalence of raised blood pressure by sex and 10-year age group from 20-29 years to 70-79 years in each study, taking into account complex survey design and survey sample weights, where relevant. We used a linear mixed effect model to quantify the association between (probittransformed) prevalence of raised blood pressure and age-group- and sex-specific mean blood pressure. We calculated the contributions of change in mean SBP and DBP, and of change in the prevalence-mean association, to the change in prevalence of raised blood pressure. Results: In 2005-16, at the same level of population mean SBP and DBP, men and women in South Asia and in Central Asia, the Middle East and North Africa would have the highest prevalence of raised blood pressure, and men and women in the highincome Asia Pacific and high-income Western regions would have the lowest. In most region-sex-age groups where the prevalence of raised blood pressure declined, one half or more of the decline was due to the decline in mean blood pressure. Where prevalence of raised blood pressure has increased, the change was entirely driven by increasing mean blood pressure, offset partly by the change in the prevalence-mean association. Conclusions: Change in mean blood pressure is the main driver of the worldwide change in the prevalence of raised blood pressure, but change in the high-blood-pressure tail of the distribution has also contributed to the change in prevalence, especially in older age groups